We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer/BioNTech’s Vaccine Holds Up Against UK, South African Coronavirus Variants in In Vitro Studies
Pfizer/BioNTech’s Vaccine Holds Up Against UK, South African Coronavirus Variants in In Vitro Studies
Researchers from Pfizer and the University of Texas Medical Branch have found that the Pfizer/BioNTech COVID-19 vaccine was still able to effectively neutralize key mutations in the highly contagious UK and South African coronavirus strains, offering hope that the prominent vaccine won’t need to be readjusted at this point.